These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 16837890
1. First-time proof of endometrial safety of the special black cohosh extract (Actaea or Cimicifuga racemosa extract) CR BNO 1055. Raus K, Brucker C, Gorkow C, Wuttke W. Menopause; 2006; 13(4):678-91. PubMed ID: 16837890 [Abstract] [Full Text] [Related]
2. Effects of black cohosh extract on body weight gain, intra-abdominal fat accumulation, plasma lipids and glucose tolerance in ovariectomized Sprague-Dawley rats. Rachoń D, Vortherms T, Seidlová-Wuttke D, Wuttke W. Maturitas; 2008; 60(3-4):209-15. PubMed ID: 18691839 [Abstract] [Full Text] [Related]
3. The non-estrogenic alternative for the treatment of climacteric complaints: Black cohosh (Cimicifuga or Actaea racemosa). Wuttke W, Jarry H, Haunschild J, Stecher G, Schuh M, Seidlova-Wuttke D. J Steroid Biochem Mol Biol; 2014 Jan; 139():302-10. PubMed ID: 23459142 [Abstract] [Full Text] [Related]
4. An isopropanolic extract of black cohosh does not increase mammographic breast density or breast cell proliferation in postmenopausal women. Hirschberg AL, Edlund M, Svane G, Azavedo E, Skoog L, von Schoultz B. Menopause; 2007 Jan; 14(1):89-96. PubMed ID: 17019374 [Abstract] [Full Text] [Related]
5. Efficacy and safety of isopropanolic black cohosh extract for climacteric symptoms. Osmers R, Friede M, Liske E, Schnitker J, Freudenstein J, Henneicke-von Zepelin HH. Obstet Gynecol; 2005 May; 105(5 Pt 1):1074-83. PubMed ID: 15863547 [Abstract] [Full Text] [Related]
6. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study. Wuttke W, Gorkow C, Seidlová-Wuttke D. Menopause; 2006 May; 13(2):185-96. PubMed ID: 16645532 [Abstract] [Full Text] [Related]
7. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Wuttke W, Seidlová-Wuttke D, Gorkow C. Maturitas; 2003 Mar 14; 44 Suppl 1():S67-77. PubMed ID: 12609561 [Abstract] [Full Text] [Related]
8. The Cimicifuga racemosa special extract BNO 1055 prevents hot flashes in ovariectomized rats. Kapur P, Wuttke W, Seidlova-Wuttke D. Phytomedicine; 2010 Sep 14; 17(11):890-4. PubMed ID: 20696560 [Abstract] [Full Text] [Related]
9. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial. Frei-Kleiner S, Schaffner W, Rahlfs VW, Bodmer Ch, Birkhäuser M. Maturitas; 2005 Aug 16; 51(4):397-404. PubMed ID: 16039414 [Abstract] [Full Text] [Related]
10. One-year endometrial safety evaluation of a continuous combined transdermal matrix patch delivering low-dose estradiol-norethisterone acetate in postmenopausal women. Samsioe G, Dvorak V, Genazzani AR, Hamann B, Heikkinen J, Mueck AO, Suzin J, Kawakami FT, Ferreira A, Sun D, Arguinzoniz M. Maturitas; 2007 Jun 20; 57(2):171-81. PubMed ID: 17317046 [Abstract] [Full Text] [Related]
11. Lack of promotion of estrogen-dependent mammary gland tumors in vivo by an isopropanolic Cimicifuga racemosa extract. Freudenstein J, Dasenbrock C, Nisslein T. Cancer Res; 2002 Jun 15; 62(12):3448-52. PubMed ID: 12067987 [Abstract] [Full Text] [Related]
12. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study. Reed SD, Newton KM, LaCroix AZ, Grothaus LC, Grieco VS, Ehrlich K. Menopause; 2008 Jun 15; 15(1):51-8. PubMed ID: 18257142 [Abstract] [Full Text] [Related]
13. Effects of black cohosh (Cimicifuga racemosa) and estrogen on metaphyseal fracture healing in the early stage of osteoporosis in ovariectomized rats. Kolios L, Schumann J, Sehmisch S, Rack T, Tezval M, Seidlova-Wuttke D, Frosch KH, Stuermer KM, Stuermer EK. Planta Med; 2010 Jun 15; 76(9):850-7. PubMed ID: 20104444 [Abstract] [Full Text] [Related]
14. Long-term endometrial and breast safety of a specific, standardized soy extract. Palacios S, Pornel B, Vázquez F, Aubert L, Chantre P, Marès P. Climacteric; 2010 Aug 15; 13(4):368-75. PubMed ID: 20380569 [Abstract] [Full Text] [Related]
15. Phytoestrogens: endocrine disrupters or replacement for hormone replacement therapy? Wuttke W, Jarry H, Becker T, Schultens A, Christoffel V, Gorkow C, Seidlová-Wuttke D. Maturitas; 2003 Mar 14; 44 Suppl 1():S9-20. PubMed ID: 12609555 [Abstract] [Full Text] [Related]
16. Black cohosh: efficacy, safety, and use in clinical and preclinical applications. McKenna DJ, Jones K, Humphrey S, Hughes K. Altern Ther Health Med; 2001 Mar 14; 7(3):93-100. PubMed ID: 11347288 [Abstract] [Full Text] [Related]
17. Endometrial safety assessment of a specific and standardized soy extract according to international guidelines. Palacios S, Pornel B, Bergeron C, Chantre P, Nogales F, Aubert L, Vazquez F, Eden J, Mares P. Menopause; 2007 Mar 14; 14(6):1006-11. PubMed ID: 17603393 [Abstract] [Full Text] [Related]
18. [Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms]. Bai WP, Wang SY, Liu JL, Geng L, Hu LN, Zhang ZL, Chen SL, Zheng SR. Zhonghua Fu Chan Ke Za Zhi; 2009 Aug 14; 44(8):597-600. PubMed ID: 20003788 [Abstract] [Full Text] [Related]
19. Black cohosh with or without St. John's wort for symptom-specific climacteric treatment--results of a large-scale, controlled, observational study. Briese V, Stammwitz U, Friede M, Henneicke-von Zepelin HH. Maturitas; 2007 Aug 20; 57(4):405-14. PubMed ID: 17590291 [Abstract] [Full Text] [Related]
20. Effects and safety of Pueraria mirifica on lipid profiles and biochemical markers of bone turnover rates in healthy postmenopausal women. Manonai J, Chittacharoen A, Udomsubpayakul U, Theppisai H, Theppisai U. Menopause; 2008 Aug 20; 15(3):530-5. PubMed ID: 18202589 [Abstract] [Full Text] [Related] Page: [Next] [New Search]